Modulation of urelumab glycosylation separates immune stimulatory activity from organ toxicity
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.970290
Abstract: Checkpoint control and immunomodulatory antibodies have become important tools for modulating tumor or self-reactive immune responses. A major issue preventing to make full use of the potential of these immunomodulatory antibodies are the severe side-effects,… read more here.
Keywords: immunomodulatory antibodies; toxicity; checkpoint control; side effects ... See more keywords